CORE-006: BEHAVORIAL MEASUREMENT SHARED RESOURCE (BMSR) PROJECT SUMMARY / ABSTRACT The Behavioral Measurement Shared Resource (BMSR) provides expert assistance and services for integrating behavioral and epidemiological research into the research goals of the OSUCCC. The BMSR maintained a high level of usage over the last grant period and provided, or is currently providing, key support for several increasingly large NCI-funded projects and OSUCCC initiatives. It is directed by Dr. Paul Reiter (CC) and the Senior Faculty Advisor is Dr. Michael Slater (CC). The BMSR offers services in five primary areas: 1) research design; 2) behavioral and survey assessment; 3) participant recruitment, accrual and retention; 4) data collection (both quantitative and qualitative data); and 5) population-based data retrieval. Thus, the BMSR provides a continuum of services for research projects, ranging from planning and development of research proposals and projects through data collection and the interpretation of research data.
The Specific Aims are to: 1) provide expertise in research design and behavioral and survey assessment; 2) assist investigators with participant recruitment, accrual and retention to ensure the inclusion of research participants that are broadly representative of the target population(s); and, 3) provide expertise and services for the collection and management of both quantitative and qualitative research data. The BMSR supports increasingly complex studies including population-based cohort studies, universal consenting for all OSUCCC patients into the Total Cancer Care protocol for biobanking, and the statewide colorectal cancer initiative accruing cancer patients and their families across the state of Ohio. Over the last five years, the BMSR supported investigators from all 5 research programs an, contributed to 58 publications and provided services to over 10 NCI funded grants, including 2 NCI P50 Centers. Future plans for the BMSR are to offer support with call management software; ecological momentary assessment (EMA); gain expertise in additional online data collection software programs including mobile applications; and, offering the use of geographic information systems (GIS) software. The BMSR leverages extensive institutional support and seeks only 9.5% support from CCSG funds. The Behavioral Measurement Shared Resource is part of the Quantitative Grouping.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Center Core Grants (P30)
Project #
Application #
Study Section
Subcommittee I - Career Development (NCI)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Ohio State University
United States
Zip Code
Bolyard, Chelsea; Meisen, W Hans; Banasavadi-Siddegowda, Yeshavanth et al. (2017) BAI1 Orchestrates Macrophage Inflammatory Response to HSV Infection-Implications for Oncolytic Viral Therapy. Clin Cancer Res 23:1809-1819
Schuh, Elizabeth M; Portela, Roberta; Gardner, Heather L et al. (2017) Safety and efficacy of targeted hyperthermia treatment utilizing gold nanorod therapy in spontaneous canine neoplasia. BMC Vet Res 13:294
Kumar, Bhavna; Yadav, Arti; Brown, Nicole V et al. (2017) Nuclear PRMT5, cyclin D1 and IL-6 are associated with poor outcome in oropharyngeal squamous cell carcinoma patients and is inversely associated with p16-status. Oncotarget 8:14847-14859
Miller, Cecelia R; Ruppert, Amy S; Fobare, Sydney et al. (2017) The long noncoding RNA, treRNA, decreases DNA damage and is associated with poor response to chemotherapy in chronic lymphocytic leukemia. Oncotarget 8:25942-25954
Pearlman, Rachel; Frankel, Wendy L; Swanson, Benjamin et al. (2017) Prevalence and Spectrum of Germline Cancer Susceptibility Gene Mutations Among Patients With Early-Onset Colorectal Cancer. JAMA Oncol 3:464-471
Farren, Matthew R; Hennessey, Rebecca C; Shakya, Reena et al. (2017) The Exportin-1 Inhibitor Selinexor Exerts Superior Antitumor Activity when Combined with T-Cell Checkpoint Inhibitors. Mol Cancer Ther 16:417-427
Teng, Kun-Yu; Han, Jianfeng; Zhang, Xiaoli et al. (2017) Blocking the CCL2-CCR2 Axis Using CCL2-Neutralizing Antibody Is an Effective Therapy for Hepatocellular Cancer in a Mouse Model. Mol Cancer Ther 16:312-322
Russell, Luke; Bolyard, Chelsea; Banasavadi-Siddegowda, Yeshavanth et al. (2017) Sex as a biological variable in response to temozolomide. Neuro Oncol 19:873-874
Terrazas, Cesar; de Dios Ruiz-Rosado, Juan; Amici, Stephanie A et al. (2017) Helminth-induced Ly6Chi monocyte-derived alternatively activated macrophages suppress experimental autoimmune encephalomyelitis. Sci Rep 7:40814
Saporito, Donika; Brock, Pamela; Hampel, Heather et al. (2017) Penetrance of a rare familial mutation predisposing to papillary thyroid cancer. Fam Cancer :

Showing the most recent 10 out of 2211 publications